Suppr超能文献

强毒土拉弗朗西斯菌Schu S4对人树突状细胞功能的直接和间接损害

Direct and indirect impairment of human dendritic cell function by virulent Francisella tularensis Schu S4.

作者信息

Chase Jennifer C, Celli Jean, Bosio Catharine M

机构信息

Immunity to Pulmonary Pathogens Section, Laboratory of Intracellular Parasites, Rocky Mountain Laboratories, National Institute of Allergy and Infectious Diseases, National Institutes of Health, 303 S. 4th St. Hamilton, MT 59840, USA.

出版信息

Infect Immun. 2009 Jan;77(1):180-95. doi: 10.1128/IAI.00879-08. Epub 2008 Nov 3.

Abstract

The gram-negative, facultative intracellular bacterium Francisella tularensis causes acute, lethal pneumonic disease following infection with only 10 CFU. The mechanisms used by the bacterium to accomplish this in humans are unknown. Here, we demonstrate that virulent, type A F. tularensis strain Schu S4 efficiently infects and replicates in human myeloid dendritic cells (DCs). Despite exponential replication over time, Schu S4 failed to stimulate transforming growth factor beta, interleukin-10 (IL-10), IL-6, IL-1beta, IL-12, tumor necrosis factor alpha, alpha interferon (IFN-alpha), and IFN-beta throughout the course of infection. Schu S4 also suppressed the ability of directly infected DCs to respond to different Toll-like receptor agonists. Furthermore, we also observed functional inhibition of uninfected bystander cells. This inhibition was mediated, in part, by a heat-stable bacterial component. Lipopolysaccharide (LPS) from Schu S4 was present in Schu S4-conditioned medium. However, Schu S4 LPS was weakly inflammatory and failed to induce suppression of DCs at concentrations below 10 microg/ml, and depletion of Schu S4 LPS did not significantly alleviate the inhibitory effect of Schu S4-conditioned medium in uninfected human DCs. Together, these data show that type A F. tularensis interferes with the ability of a central cell type of the immune system, DCs, to alert the host of infection both intra- and extracellularly. This suggests that immune dysregulation by F. tularensis operates on a broader and more comprehensive scale than previously appreciated.

摘要

革兰氏阴性兼性胞内菌土拉弗朗西斯菌仅在感染10个集落形成单位(CFU)后就能引发急性致死性肺炎疾病。该细菌在人类中实现这一过程的机制尚不清楚。在此,我们证明了强毒A型土拉弗朗西斯菌菌株Schu S4能有效地感染人类髓样树突状细胞(DCs)并在其中复制。尽管随着时间推移呈指数级复制,但在整个感染过程中,Schu S4未能刺激转化生长因子β、白细胞介素-10(IL-10)、IL-6、IL-1β、IL-12、肿瘤坏死因子α、α干扰素(IFN-α)和IFN-β。Schu S4还抑制了直接感染的DCs对不同Toll样受体激动剂作出反应的能力。此外,我们还观察到未感染的旁观者细胞的功能受到抑制。这种抑制部分是由一种热稳定的细菌成分介导的。来自Schu S4的脂多糖(LPS)存在于Schu S4条件培养基中。然而,Schu S4 LPS的炎症反应较弱,在浓度低于10微克/毫升时未能诱导对DCs的抑制作用,并且去除Schu S4 LPS并没有显著减轻Schu S4条件培养基对未感染人类DCs的抑制作用。总之,这些数据表明A型土拉弗朗西斯菌会干扰免疫系统的一种核心细胞类型DCs在细胞内和细胞外提醒宿主感染的能力。这表明土拉弗朗西斯菌引起的免疫失调比之前认为的作用范围更广、更全面。

相似文献

1
Direct and indirect impairment of human dendritic cell function by virulent Francisella tularensis Schu S4.
Infect Immun. 2009 Jan;77(1):180-95. doi: 10.1128/IAI.00879-08. Epub 2008 Nov 3.
2
Interactions of Francisella tularensis with Alveolar Type II Epithelial Cells and the Murine Respiratory Epithelium.
PLoS One. 2015 May 26;10(5):e0127458. doi: 10.1371/journal.pone.0127458. eCollection 2015.
5
Complement C3 as a Prompt for Human Macrophage Death during Infection with Francisella tularensis Strain SCHU S4.
Infect Immun. 2017 Sep 20;85(10). doi: 10.1128/IAI.00424-17. Print 2017 Oct.
6
Macrophages Demonstrate Guanylate-Binding Protein-Dependent and Bacterial Strain-Dependent Responses to .
Front Cell Infect Microbiol. 2021 Dec 24;11:784101. doi: 10.3389/fcimb.2021.784101. eCollection 2021.
8
Contribution of citrulline ureidase to Francisella tularensis strain Schu S4 pathogenesis.
J Bacteriol. 2009 Aug;191(15):4798-806. doi: 10.1128/JB.00212-09. Epub 2009 Jun 5.
9
Role of primary human alveolar epithelial cells in host defense against Francisella tularensis infection.
Infect Immun. 2007 Aug;75(8):3969-78. doi: 10.1128/IAI.00157-07. Epub 2007 May 14.
10
Characterization of Francisella tularensis Schu S4 defined mutants as live-attenuated vaccine candidates.
Pathog Dis. 2015 Aug;73(6):ftv036. doi: 10.1093/femspd/ftv036. Epub 2015 May 17.

引用本文的文献

2
Merocytophagy is an integrin-stabilized macrophage response to microbes reliant on Syk signaling.
Front Immunol. 2025 Apr 17;16:1565250. doi: 10.3389/fimmu.2025.1565250. eCollection 2025.
3
Route of Francisella tularensis infection informs spatiotemporal metabolic reprogramming and inflammation in mice.
PLoS One. 2023 Oct 26;18(10):e0293450. doi: 10.1371/journal.pone.0293450. eCollection 2023.
4
Activation of Toll-Like Receptors by Live Gram-Negative Bacterial Pathogens Reveals Mitigation of TLR4 Responses and Activation of TLR5 by Flagella.
Front Cell Infect Microbiol. 2021 Nov 23;11:745325. doi: 10.3389/fcimb.2021.745325. eCollection 2021.
6
A predicted DXD-motif glycosyltransferase blocks immune activation.
Virulence. 2019 Dec;10(1):643-656. doi: 10.1080/21505594.2019.1631662.
7
Unique Francisella Phosphatidylethanolamine Acts as a Potent Anti-Inflammatory Lipid.
J Innate Immun. 2018;10(4):291-305. doi: 10.1159/000489504. Epub 2018 Jul 3.
10
Confronts the Complement System.
Front Cell Infect Microbiol. 2017 Dec 19;7:523. doi: 10.3389/fcimb.2017.00523. eCollection 2017.

本文引用的文献

1
Genome-wide in silico mapping of the secretome in pathogenic Yersinia pestis KIM.
FEMS Microbiol Lett. 2008 Feb;279(1):56-63. doi: 10.1111/j.1574-6968.2007.01008.x. Epub 2007 Dec 7.
2
Activation of the inflammasome upon Francisella tularensis infection: interplay of innate immune pathways and virulence factors.
Cell Microbiol. 2007 Nov;9(11):2543-51. doi: 10.1111/j.1462-5822.2007.01022.x. Epub 2007 Jul 27.
3
Identification of a Porphyromonas gingivalis novel protein sov required for the secretion of gingipains.
Microbiol Immunol. 2007;51(5):483-91. doi: 10.1111/j.1348-0421.2007.tb03936.x.
4
Type VI secretion is a major virulence determinant in Burkholderia mallei.
Mol Microbiol. 2007 Jun;64(6):1466-85. doi: 10.1111/j.1365-2958.2007.05734.x.
5
Role of primary human alveolar epithelial cells in host defense against Francisella tularensis infection.
Infect Immun. 2007 Aug;75(8):3969-78. doi: 10.1128/IAI.00157-07. Epub 2007 May 14.
6
Type I interferon signaling is required for activation of the inflammasome during Francisella infection.
J Exp Med. 2007 May 14;204(5):987-94. doi: 10.1084/jem.20062665. Epub 2007 Apr 23.
7
The Francisella pathogenicity island.
Ann N Y Acad Sci. 2007 Jun;1105:122-37. doi: 10.1196/annals.1409.000. Epub 2007 Mar 29.
8
Active suppression of the pulmonary immune response by Francisella tularensis Schu4.
J Immunol. 2007 Apr 1;178(7):4538-47. doi: 10.4049/jimmunol.178.7.4538.
9
Modulation of virulence factors in Francisella tularensis determines human macrophage responses.
Microb Pathog. 2007 May-Jun;42(5-6):204-14. doi: 10.1016/j.micpath.2007.02.001. Epub 2007 Feb 15.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验